a

Osiris Provides an Update on a Clinical Review by Blue Cross Blue Shield Association

COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing…